Basic Science: AKI-Specific Early Interventions Workgroup

AKINow Basic Science Workgroup Mission

Innovate AKI prevention, diagnosis, and treatment by leveraging basic science discoveries.

  AKINow Basic Science Spotlight


WP_Term Object
(
    [term_id] => 26
    [name] => AKINow
    [slug] => akinow
    [term_group] => 0
    [term_taxonomy_id] => 26
    [taxonomy] => spotlight_cat
    [description] => Acute Kidney Injury
    [parent] => 0
    [count] => 13
    [filter] => raw
)
Term ID: term_26
 term_26
 https://epc.asn-online.org/projects/akinow/

AKINow Journal Club (Recorded July 20, 2023)

Recorded: Thursday, July 20, 2023

A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcome

Nat Commun 14, 2826 (2023). https://doi.org/10.1038/s41467-023-38532-3 Published May 17, 2023

In this randomized control trial, the authors investigated whether an automated clinical decision support system affects discontinuation rates of potentially nephrotoxic medications and improves outcomes in patients with AKI.

The paper’s lead author, Dr. F. Perry Wilson, discusses the study and answers questions.

Video Link opens in a new tab. Unanswered Questions from July opens in a new tab 

WP_Term Object
(
    [term_id] => 26
    [name] => AKINow
    [slug] => akinow
    [term_group] => 0
    [term_taxonomy_id] => 26
    [taxonomy] => spotlight_cat
    [description] => Acute Kidney Injury
    [parent] => 0
    [count] => 13
    [filter] => raw
)
Term ID: term_26
 term_26
 https://epc.asn-online.org/projects/akinow/

AKINow Basic Science Workgroup Goals

  • Create a compendium or centralized information portal
  • Communicate knowledge around AKI innovation more effectively – partner with Public Awareness and Education Workgroup
  • Foster innovation in education in AKI pathogenesis via coursework
  • Promote collaborations around AKI basic science
  • Establish a [pre]clinical Development roadmap